retatrutide dose clinical trial VisualAbstract: reduces body weight by 17.5% in patients with obesity Retatrutide Dosage: What Clinical Trial

Dermatologist at the Ohio State University, Susan Massick, MD, told Healthline: "Telogen effluvium [or TE] is a diffuse shedding of hair that occurs approximately three months after a major stressor." Mir Ali, MD, a California-based bariatric surgeon and medical director of MemorialCare Surgical Weight Loss Center at Orange Coast Medical Center, added: "The patients it does happen to, in my experience, notice it and see it in the hairbrush

None of this means something is wrong

Retatrutide is not yet FDA approved, unlike many GLP-1 agonists, retatrutide will most likely be a weekly injection, delivered subcutaneously into the arm, thigh or stomach area in a self-inject pen

Pink & White Nails A semi-permanent technique used for artificial nails